Parkinson’s Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs
Long non-coding RNAs (lncRNAs) have been recently reported to be involved in the pathoetiology of Parkinson’s disease (PD). Circulatory levels of lncRNAs might be used as markers for PD. In the present work, we measured expression levels of HULC, PVT1, MEG3, SPRY4-IT1, LINC-ROR and DSCAM-AS1 lncRNAs...
Guardado en:
Autores principales: | Kasra Honarmand Tamizkar, Pooneh Gorji, Mahdi Gholipour, Bashdar Mahmud Hussen, Mehrdokht Mazdeh, Solat Eslami, Mohammad Taheri, Soudeh Ghafouri-Fard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5b25aab020b2416181aeda2ce3df7746 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Concise Review on the Role of CircPVT1 in Tumorigenesis, Drug Sensitivity, and Cancer Prognosis
por: Soudeh Ghafouri-Fard, et al.
Publicado: (2021) -
Dysregulation of lncRNAs in autoimmune neuropathies
por: Mahdi Gholipour, et al.
Publicado: (2021) -
LncRNAs: Novel Biomarkers for Pancreatic Cancer
por: Soudeh Ghafouri-Fard, et al.
Publicado: (2021) -
A Review on the Role of AFAP1-AS1 in the Pathoetiology of Cancer
por: Soudeh Ghafouri-Fard, et al.
Publicado: (2021) -
Identification of oxytocin-related lncRNAs and assessment of their expression in breast cancer
por: Sepehr Behtaji, et al.
Publicado: (2021)